The International Atherosclerosis Society joins the Argentine Federation of Cardiology, the Argentine Lipid Society, the Argentine Society of Cardiology, and AterosChile for two days of science on current and emerging lipid-lowering therapies.
International experts will cover combination lipid-lowering strategies, managing very high cardiovascular risk and elevated Lp(a), residual risk, and new and emerging therapies. Sessions also cover imaging and biomarkers to guide treatment, familial hypercholesterolemia, the role of AI in cardiovascular prevention, and complex patient cases.
